Advanced Search | View Cart | Check Out | 800.284.8433
Bookmark and Share

Lynn Sage Breast Cancer Symposium

Northwestern University, Feinberg School of Medicine

The Robert H. Lurie Comprehensive Cancer Center of Northwestern University Lynn Sage Breast Cancer Symposium is available in a variety of media formats to meet your needs—DVD, MP4, MP3, and audio CD.

The 10th Annual Lynn Sage Breast Cancer Symposium is intended for individuals actively engaged clinically or scientifically in diagnostic and therapeutic radiology, oncology, surgery, gynecology, family practice, and genetics.

Program Description

The optimal management of breast cancer is rapidly evolving. A multidisciplinary team of medical, surgical and radiation oncologists, pathologists, plastic surgeons and genetic counselors are routinely involved in offering treatment recommendations for individual patients with a diagnosis of breast cancer. With the emergence of prevention strategies, women at high risk of developing breast cancer are now evaluated for medical therapies, surgical options and lifestyle changes that may reduce their risk of developing breast cancer. This activity includes a forum of discussions and presentations in laboratory and clinical research concerning the care of patients with breast cancer.

Click here for more information regarding our
future symposia in Chicago.

 
CREDITS Earn up to 19.5 AMA PRA Category 1 Credit™.
CE RELEASE December 31, 2008
CE EXPIRE January 1, 2012
 
Item No Media (Can't decide on a format?) Price Purchase
652DD
Video - DVD: Includes 9 DVDs with carrying case, 1 CD-ROM syllabus, and program evaluation.
$750.00
6524P
: Includes 2 MP4 data discs with carrying case, 1 CD-ROM Syllabus, and program evaluation.
$750.00
652CD
Audio - CD: Includes 19 audio CDs with carrying case, 1 CD-ROM Syllabus, and program evaluation.
$650.00
6523P
: Includes 1 MP3 data disc with carrying case, 1 CD-ROM Syllabus, and program evaluation.
$650.00
652DC
Combo DVD/CD Package: Includes 9 DVDs plus 19 audio CDs with carrying case, 1 CD-ROM Syllabus, and program evaluation.
$995.00
652D3
Combo DVD/MP3 Package: Includes 9 DVDs plus 1 MP3 data disc with carrying case, 1 CD-ROM Syllabus, and program evaluation.
$995.00
6524C
Combo MP4/CD Package: Includes 2 MP4 data discs plus 19 audio CDs with carrying case, 1 CD-ROM Syllabus, and program evaluation.
$995.00
65243
Combo MP4/MP3 Package: Includes 2 MP4 data discs plus 1 MP3 data disc with carrying case, 1 CD-ROM Syllabus, and program evaluation.
$995.00
652AUP
Additional User Package: Includes 1 CD-ROM Syllabus and program evaluation (initial video and/or audio purchase required).
$250.00
 
Special pricing for clinic-wide orders or for group subscriptions/purchases. Minimum order quantities apply for eligible discounts. For further information and pricing estimates, contact Kyle Jackson at 1-800-952-0690 x3075.
 

Program Information


Some highlights of the program include:
  • Cognitive Dysfunction Following Breast Cancer Therapy
  • Managing Quality of Life Following Completion of Adjuvant Therapy
  • Current Issues in HER2 Testing
  • Screening for Diagnosis: Guidelines forMammography &MRI
  • Estrogen in the Life and Death of Breast Cancer Cells
  • The Approach to Reconstruction in the Era of Post Mastectomy Radiotherapy
  • Predicting Sensitivity to Chemotherapy with Genomic Profiling
  • DEBATE: The Timing of Sentinel Node Biopsy (SN BX) in the Patient Receiving Neoadjuvant TreatmentBefore Chemotherapy
  • Disparities in Breast Cancer: Biology or Access
  • The Conundrum of Sentinel NodeMicrometastases

Educational Objectives

After viewing this activity, participants will be able to:
  • Identify new treatment strategies for managing cancer-associated pain, learn to communicate compassionately and honestly about disease status and understand ways tomanage the long–term side effects of adjuvant therapy in breast cancer survivors
  • Describe controversies regarding different HER2 testing methods, understand recent data regarding new prognostic and predictive molecular and clinical markers, identify implications of a diagnosis of lobular carcinoma in situ and describe the issues following a core needle biopsy diagnosis of breast cancer
  • Describe and understand the optimal systemic therapy to reduce the risk of recurrence in patients with early stage breast cancer
  • Describe the advances made in identifying patients with genetic abnormalities that increase risk for developing breast cancer
  • Describe and understand the reconstructive surgical options available to patients with early stage breast cancer
  • Describe and understand the gene expression patterns in tumor tissue that correlate with response or resistance to anti-cancer therapies
  • Describe the potential benefits and risks of partial breast irradiation techniques

 
 

Topics & Speakers


Supportive Care Symposium

  • Update on Pain Management
    Judith Paice, PhD, RN
  • Cognitive Dysfunction Following
    Breast Cancer Therapy
    Ian Tannock, MD, PhD
  • Transitions: What to Say When There is
    Nothing Good to Say
    Robert Buckman, MD
  • Managing Quality of Life Following Completion
    of Adjuvant Therapy
    Jamie Von Roenn, MD
  • Questions and Answers

Pathology for the Non-Pathologist

  • Evolving Concepts in Lobular Neoplasia
    Barbara Susnik, MD, PhD
  • Management Issues Following Core Biopsy
    Carol Reynolds, MD
  • Prognostic and Predictive Markers
    W. Fraser Symmons, MD
  • Panel Discussion
    Moderator-Charles Clevenger, MD, PhD

Diagnosis and Prevention

  • Screening for Diagnosis: Guidelines for
    Mammography & MRI
    David Dershaw, MD, FACR
  • Screening for Metastases: What’s Appropriate,
    What’s Not
    Eric Winer, MD
  • What’s New in Breast Cancer Genetics?
    Virginia Kaklamani, MD, DSc
  • Tackling Obesity
    Rowan Chlebowski, MD, PhD
  • Questions and Answers

Lynn Sage Distinguished Lecturer

  • Estrogen in the Life and Death of Breast Cancer Cells
    V. Craig Jordan OBE, PhD, DScc

Controversies in Local Therapy:
Radiotherapy and Plastic Surgery

  • The Impact of Reconstruction on Post
    Mastectomy Radiotherapy
    Welela Tereffe, MD
  • The Approach to Reconstruction in the Era of Post Mastectomy Radiotherapy
    Neal Topham, MD
  • Current Status of Partial Breast Irradiation
    Frank Vicini, MD
  • Nipple Sparing Mastectomy
    Nora Hansen, MD
  • Questions and Answers

Panel on Unusual Breast Problems

  • Management of an Ovarian Mass in a Patient
    Breast Cancer
    Moderator: William Gradishar, MD
  • Patient With Isolated Recurrence in the Internal Mammary Nodes After a Negative Initial Sentinal
    Lymph Node Biopsy
    Moderator: William Gradishar, MD

From the Laboratory to the Clinic

  • Breast Cancer Genomics: Ready for Prime Time?
    Charles Perou, PhD
  • Predicting Sensitivity to Chemotherapy
    with Genomic Profiling
    Jenny Chang, MD
  • Circulating Tumor Cells
    Daniel Hayes, MD
  • Questions and Answers

DEBATE: The Timing of Sentinel Node Biopsy
(SN BX) in the Patient Receiving Neoadjuvant Treatment

  • Before Chemotherapy
    Jay Harris, MD
  • After Chemotherapy
    Henry Kuerer, MD, PhD
  • Questions and Answers

Controversies in Systemic Therapy

  • HER2 Testing: What’s Real, What’s Not?
    Antonio Wolff, MD
  • HER2 and the Heart
    William Gradishar, MD
  • Rethinking Chemotherapy in the HER2+ Patient
    Dennis Slamon, MD, PhD
  • What’s New in Endocrine Therapy
    Ruth O’Regan, MD
  • Questions and Answers
  • Audience Response Case Reviews
    Moderator: Monica Morrow, MD

Evolving Topics in Breast Cancer

  • Management of DCIS
    Monica Morrow, MD
  • Disparities in Breast Cancer: Biology or Access
    Lisa Newman, MD, MPH
  • What’s New for Metastatic Disease
    Clifford Hudis, MD
  • New Insights into Lobular Carcinoma
    Seema Khan, MD
  • The Conundrum of Sentinel Node Micrometastases
    Armando Giuliano, MD
  • Questions and Answers

Faculty

 
Robert Buckman, MD
Princess Margaret Hospital

Jenny Chang, MD
Baylor College of Medicine

Rowan Chlebowksi, MD, PhD
Los Angeles Biomedical Institute at Harbor –
UCLA Medical Center


Julia Choo, MD
Robert H. Lurie Comprehensive Cancer Center
of Northwestern University


Mary Cianfrocca, DO
Robert H. Lurie Comprehensive Cancer Center
of Northwestern University


Charles Clevenger, MD, PhD
Robert H. Lurie Comprehensive Cancer Center
of Northwestern University


David Dershaw, MD, FACR
Memorial Sloan-Kettering Cancer Center

Armando Giuliano, MD
John Wayne Cancer Institute

Allen Gown, MD
PhenoPath Laboratories

William Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center
of Northwestern University


Nora Hansen, MD
Robert H. Lurie Comprehensive Cancer Center
of Northwestern University


Jay Harris, MD
Dana-Farber Cancer Institute

Daniel Hayes, MD
University of Michigan

Clifford Hudis, MD
Memorial Sloan-Kettering Cancer Center

Jacqueline Jeruss, MD, PhD
Robert H. Lurie Comprehensive Cancer Center
of Northwestern University


V. Craig Jordan, OBE, PhD, DSc
Fox Chase Cancer Center

Virginia Kaklamani, MD, DSc
Robert H. Lurie Comprehensive Cancer Center
of Northwestern University

Seema Khan, MD
Robert H. Lurie Comprehensive Cancer Center
of Northwestern University


Henry Kuerer, MD, PhD
University of Texas, MD Anderson Cancer Center

Monica Morrow, MD
Memorial Sloan-Kettering Cancer Center

Lisa Newman, MD, MPH
University of Michigan

Ruth O’Regan, MD
Emory University Winship Cancer Institute

Judith Paice, PhD, RN
Robert H. Lurie Comprehensive Cancer Center
of Northwestern University

Charles Perou, PhD
Lineberger Comprehensive Cancer Center,
University of North Carolina


Carol Reynolds, MD
Mayo Clinic

Carol Schiller, MD
Robert H. Lurie Comprehensive Cancer Center
of Northwestern University


Diljeet Singh, MD, DrPH
Robert H. Lurie Comprehensive Cancer Center
of Northwestern University


Dennis Slamon, MD, PhD
University of California at Los Angeles

Barbara Susnik, MD, PhD
Robert H. Lurie Comprehensive Cancer Center
of Northwestern University


W. Fraser Symmans, MD
University of Texas, MD Anderson Cancer Center

Ian Tannock, MD, PhD
Princess Margaret Hospital/University Health Network

Welela Tereffe, MD
University of Texas, MD Anderson Cancer Center

Neal Topham, MD
Fox Chase Cancer Center

Frank Vicini, MD, FACR
William Beaumont Hospital

Jamie Von Roenn, MD
Robert H. Lurie Comprehensive Cancer Center
of Northwestern University


Eric Winer, MD
Harvard Medical Center

Antonio Wolff, MD
The Sidney Kimmel Comprehensive Cancer Center
at Johns Hopkins


 
 

Accreditation Statement


Northwestern University, Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Northwestern University, Feinberg School of Medicine designates this educational activity for a maximum of 19.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Date of Original Release: December 31, 2008
Termination Date: January 1, 2012

CME credit is obtained upon successful completion of an activity evalution, as well as payment of a $30 processing fee.